ABCB1 and colorectal carcinoma: To get further understanding on ABCB1- and ABCG2-medaited gedatolisib resistance in CRC cells, we established a gedatolisib resistance SW620 CRC cell line, SW620/GEDA, which means in that cells, gedatolisib (3 μM) could not significantly alter the cell proliferation.